Q3 2022 Holdings
Filed 2022-11-08 | 61 holdings | $109.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $51.6M | 499,824 | 47.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $25.0M | 294,750 | 22.9% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $15.5M | 320,722 | 14.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $10.0M | 381,345 | 9.2% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $5.2M | 274,330 | 4.8% |
| Karuna Therapeutics Inc | COM | 48576A100 | $466.3K | 2,073,124 | 0.4% |
| CinCor Pharma Inc | COM | 17240Y109 | $199.5K | 6,079,949 | 0.2% |
| Natera Inc(NTRA) | COM | 632307104 | $136.0K | 3,102,960 | 0.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $67.8K | 3,181,442 | 0.1% |
| Aerovate Therapeutics Inc | COM | 008064107 | $62.3K | 3,758,686 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $50.2K | 583,468 | 0.0% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $48.1K | 1,264,546 | 0.0% |
| Invesco QQQ Trust Series 1(QQQ)Put | UNIT SER 1 | 46090E103 | $40.1K | 150,000 | 0.0% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $38.5K | 701,878 | 0.0% |
| Health Care Select Sector Spdr(XLV)Put | SBI HEALTHCARE | 81369Y209 | $36.3K | 300,000 | 0.0% |
| iShares Russell 2000 ETF(IWM)Put | RUSSELL 2000 ETF | 464287655 | $33.0K | 200,000 | 0.0% |
| Y-mAbs Therapeutics Inc(YMABUSD) | COM | 984241109 | $31.6K | 2,194,278 | 0.0% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $30.9K | 147,564 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $29.8K | 482,400 | 0.0% |
| Merck & Co Inc(MRK)Call | COM | 58933Y105 | $25.8K | 300,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $21.0K | 3,612,376 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $20.6K | 818,376 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM | 46120E602 | $18.1K | 96,300 | 0.0% |
| iRhythm Technologies Inc(IRTC) | COM | 450056106 | $17.6K | 140,095 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $16.6K | 205,948 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $15.6K | 141,440 | 0.0% |
| Iveric Bio Inc(OPHTEUR) | COM | 46583P102 | $14.7K | 820,665 | 0.0% |
| Lilly Eli & Co(LLY) | COM | 532457108 | $14.7K | 45,500 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $12.6K | 583,357 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $12.6K | 525,002 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $12.2K | 147,200 | 0.0% |
| Akouos Inc | COM | 00973J101 | $10.2K | 1,515,074 | 0.0% |
| Inozyme Pharm Inc | COM | 45790W108 | $9.8K | 3,655,308 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $9.8K | 654,756 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $9.7K | 394,678 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $8.2K | 139,774 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $8.1K | 450,177 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $7.3K | 2,671,856 | 0.0% |
| Adicet Bio Inc(TORCEUR) | COM | 007002108 | $7.0K | 491,965 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $6.5K | 797,262 | 0.0% |
| Inhibrx Inc(INBXUSD)Put | COM | 45720L107 | $6.3K | 350,000 | 0.0% |
| Nucana Biomed | SPONSORED ADR | 67022C106 | $5.9K | 5,599,999 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $5.7K | 287,901 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $5.7K | 213,959 | 0.0% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $5.4K | 3,083,712 | 0.0% |
| Immatics NV(IMTX) | SHS | N44445109 | $5.3K | 532,516 | 0.0% |
| Agenus Inc(AGENEUR) | COM | 00847G705 | $5.0K | 2,437,465 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.8K | 220,665 | 0.0% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $4.1K | 2,754,437 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $2.8K | 1,189,208 | 0.0% |